PharmaShots | Incisive News in 3 Shots

Subscribe Now

AltruBio

AltruBio Receives the US FDA’s IND Clearance to Initiate a P-II Clinical Trial of ALTB-268 for Ulcerative Colitis

AltruBio Receives the US FDA’s IND Clearance to Initiate a P-II Clinical Trial of ALTB-268 for Ulcerative Colitis

September 27, 2023

$AltruBio Reports the Completion of Patient Enrollment in P-I Clinical Study of Neihulizumab (ALTB-168) for Steroid-Refractory Acute Graft-Versus-Host Disease$

AltruBio Reports the Completion of Patient Enrollment in P-I Clinical Study of Neihulizumab (ALTB-168) for Steroid-Refractory Acut...

May 13, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us